Junko Murai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Lipopolysaccharide Induced

Top Venues

Communications biology

Molecular cancer therapeutics

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroshi Onji, Sota Tate, Tomohisa Sakaue, Kohei Fujiwara, Shiho Nakano, Miho Kawaida, Nobuyuki Onishi, Takashi Matsumoto, Wataru Yamagami, Takashi Sugiyama, Shigeki Higashiyama, Yves Pommier, Yusuke Kobayashi, Junko Murai
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks. Oncogene 43 (32) (2024)
Hiroshi Onji, Sota Tate, Tomohisa Sakaue, Kohei Fujiwara, Shiho Nakano, Miho Kawaida, Nobuyuki Onishi, Takashi Matsumoto, Wataru Yamagami, Takashi Sugiyama, Shigeki Higashiyama, Yves Pommier, Yusuke Kobayashi, Junko Murai
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks. Oncogene 43 (32) (2024)
Hiroshi Onji, Sota Tate, Tomohisa Sakaue, Kohei Fujiwara, Shiho Nakano, Miho Kawaida, Nobuyuki Onishi, Takashi Matsumoto, Wataru Yamagami, Takashi Sugiyama, Shigeki Higashiyama, Yves Pommier, Yusuke Kobayashi, Junko Murai
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks. Oncogene 43 (32) (2024)
Hiroshi Onji, Sota Tate, Tomohisa Sakaue, Kohei Fujiwara, Shiho Nakano, Miho Kawaida, Nobuyuki Onishi, Takashi Matsumoto, Wataru Yamagami, Takashi Sugiyama, Shigeki Higashiyama, Yves Pommier, Yusuke Kobayashi, Junko Murai
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks. Oncogene 43 (32) (2024)
Hiroshi Onji, Sota Tate, Tomohisa Sakaue, Kohei Fujiwara, Shiho Nakano, Miho Kawaida, Nobuyuki Onishi, Takashi Matsumoto, Wataru Yamagami, Takashi Sugiyama, Shigeki Higashiyama, Yves Pommier, Yusuke Kobayashi, Junko Murai
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks. Oncogene (2024)
Junko Murai, Michele Ceribelli, Haiqing Fu, Christophe E Redon, Ukhyun Jo, Yasuhisa Murai, Mirit I Aladjem, Craig J Thomas, Yves Pommier
Schlafen 11 (SLFN11) kills cancer cells undergoing unscheduled re-replication. Molecular cancer therapeutics (2023)
Christopher Noyes, Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac, Nagib Ahsan, Erik Knelson, Amir Vajdi, Tetsuo Tani, Tran C Thai, Derek Xu, Junko Murai, Nikos Tapinos, Chiaki Takahashi, David A Barbie, Mamiko Yajima
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications biology 6 (1) (2023)
Christopher Noyes, Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac, Nagib Ahsan, Erik Knelson, Amir Vajdi, Tetsuo Tani, Tran C Thai, Derek Xu, Junko Murai, Nikos Tapinos, Chiaki Takahashi, David A Barbie, Mamiko Yajima
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications biology 6 (1) (2023)
Junko Murai, Yves Pommier
BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality. Cancer research 83 (8) (2023)
Christopher Noyes, Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac, Nagib Ahsan, Erik Knelson, Amir Vajdi, Tetsuo Tani, Tran C Thai, Derek Xu, Junko Murai, Nikos Tapinos, Chiaki Takahashi, David A Barbie, Mamiko Yajima
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications biology 6 (1) (2023)
Christopher Noyes, Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac, Nagib Ahsan, Erik Knelson, Amir Vajdi, Tetsuo Tani, Tran C Thai, Derek Xu, Junko Murai, Nikos Tapinos, Chiaki Takahashi, David A Barbie, Mamiko Yajima
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications biology 6 (1) (2023)
Hidehiko Akashi, Nozomi Yachida, Haruka Ueda, Manako Yamaguchi, Kaoru Yamawaki, Ryo Tamura, Kazuaki Suda, Tatsuya Ishiguro, Sosuke Adachi, Yoshikazu Nagase, Yutaka Ueda, Masashi Ueda, Kaoru Abiko, Masahiro Kagabu, Tsukasa Baba, Hirofumi Nakaoka, Takayuki Enomoto, Junko Murai, Kosuke Yoshihara
SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma. Molecular cancer therapeutics (2023)
Hiroshi Onji, Junko Murai
Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes. Cancer science 113 (9) (2022)
Fumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, Daiki Taniyama, Nobuyuki Onishi, Hiroshi Arima, Hiroyuki Sasanuma, Remi Akagawa, Fathi Elloumi, Shunichi Takeda, Yves Pommier, Eiichi Morii, Akifumi Takaori-Kondo, Junko Murai
Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development. PloS one 16 (1) (2021)
Tsuyoshi Takashima, Daiki Taniyama, Naoya Sakamoto, Maika Yasumoto, Ryuichi Asai, Takuya Hattori, Ririno Honma, Quoc Thang Pham, Shoichi Ukai, Ryota Maruyama, Kenji Harada, Kazuya Kuraoka, Kazuaki Tanabe, Atsuo T Sasaki, Hideki Ohdan, Eiichi Morii, Junko Murai, Wataru Yasui
Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers. British journal of cancer 125 (1) (2021)